BRIEF-Strategic partner Intega Skin Sciences Inc,acquired by Crescita Therapeutics Inc
Sept 1 (Reuters) - Knight Therapeutics Inc
* As part of Crescita acquisition, it was agreed that $3.0 million of Knight's secured loan will be repaid
* As part of Crescita deal , it was agreed that interest rate on Knight's remaining loan balance will be reduced to 9%/year
* Received 645,002 common shares of Crescita in exchange for its intega shares
* Now owns an aggregate of 1.5 million common shares of crescita, representing about 10.9% of outstanding common shares of Crescita
* Strategic partner Intega Skin Sciences Inc, a Montreal-based Dermatology Company, has been acquired by Crescita Therapeutics Inc Source text for Eikon:
© Thomson Reuters 2017 All rights reserved.